Stonegate Investment Group LLC bought a new stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,404 shares of the company’s stock, valued at approximately $216,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of DOCU. Dimensional Fund Advisors LP raised its position in DocuSign by 14.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 610,728 shares of the company’s stock valued at $32,671,000 after buying an additional 75,133 shares during the last quarter. Sei Investments Co. increased its position in shares of DocuSign by 16.4% during the 2nd quarter. Sei Investments Co. now owns 22,341 shares of the company’s stock worth $1,195,000 after purchasing an additional 3,141 shares during the last quarter. MBB Public Markets I LLC acquired a new position in shares of DocuSign during the 2nd quarter worth approximately $781,000. The Manufacturers Life Insurance Company increased its position in shares of DocuSign by 3.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 52,260 shares of the company’s stock worth $2,796,000 after purchasing an additional 1,628 shares during the last quarter. Finally, Mackenzie Financial Corp increased its position in shares of DocuSign by 25.4% during the 2nd quarter. Mackenzie Financial Corp now owns 68,833 shares of the company’s stock worth $3,683,000 after purchasing an additional 13,944 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Activity at DocuSign
In other news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total transaction of $50,516.40. Following the completion of the sale, the director now directly owns 7,736 shares in the company, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 7,764 shares of the business’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total value of $543,091.80. Following the transaction, the chief executive officer now directly owns 107,825 shares of the company’s stock, valued at $7,542,358.75. This trade represents a 6.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 693,537 shares of company stock worth $66,575,817 in the last ninety days. 1.66% of the stock is owned by company insiders.
DocuSign Price Performance
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 price target (up previously from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Morgan Stanley boosted their price target on DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Piper Sandler lifted their target price on DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, DocuSign has a consensus rating of “Hold” and an average price target of $92.45.
Read Our Latest Stock Report on DocuSign
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- How to Start Investing in Real Estate
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Overbought Stocks Explained: Should You Trade Them?
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Tickers Leading a Meme Stock Revival
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.